Lysed Platelets Shorten the Activated Coagulation Time (ACT) of Heparinized Blood
Open Access
- 1 April 1989
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 91 (4) , 430-434
- https://doi.org/10.1093/ajcp/91.4.430
Abstract
Aliquots of heparinized whole blood were incubated at 37 °C with preparations of lysed platelets or buffer. In the presence of lysed platelets, the ACT decreased to 127 seconds (±41, n = 9) versus 248 seconds (±43, n = 9) in the controls (P = 0.0002). The shortening of the ACT by lysed platelets followed a typical dose-response relationship. Fractionation of lysed platelet preparations revealed that the procoagulant membrane fraction, not the cytosol fraction containing PF4, was responsible for this effect of lysed platelets on the ACT. These findings demonstrate that the ACT can be artifactually low in the presence of heparin, indicating a potential problem in the use of the ACT for monitoring of heparin neutralization.Keywords
This publication has 10 references indexed in Scilit:
- Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery.Journal of Clinical Investigation, 1986
- Stroma free human platelet lysates potentiate the in vivo thrombogenicity of factor Xa by the provision of coagulant-active phospholipidBritish Journal of Haematology, 1982
- Differentiation of factor V-like coagulant activity from catalytic phospholipid-like surface activity in membrane fractions derived from human plateletsThrombosis Research, 1981
- Heparin Levels and Activated Clotting Time (ACT) during Open Heart SurgeryScandinavian Journal of Haematology, 1981
- Management of postoperative heparin rebound following cardiopulmonary bypassThe Journal of Thoracic and Cardiovascular Surgery, 1981
- ACTIVATED CLOTTING TIME MONITORING OF INTRA-OPERATIVE HEPARINIZATION - OUR EXPERIENCE AND COMPARISON OF 2 TECHNIQUES1981
- Evaluation of the Activated Whole Blood Clotting Time (ACT) in VitroScandinavian Journal of Haematology, 1979
- HEPARIN ADMINISTRATION DURING EXTRACORPOREAL-CIRCULATION - HEPARIN REBOUND AND POST-OPERATIVE BLEEDING1979
- FACTOR-V ACTIVITY OF PLATELETS - EVIDENCE FOR AN ACTIVATED FACTOR-V MOLECULE AND FOR A PLATELET ACTIVATOR1977
- Progress Report: The Activated Coagulation Time of Whole Blood (ACT)American Journal of Clinical Pathology, 1976